Design, synthesis, and computational studies of inhibitors of Bcl-XL.

@article{Park2006DesignSA,
  title={Design, synthesis, and computational studies of inhibitors of Bcl-XL.},
  author={Cheol-Min Park and T. Hasegawa M. Oie and Andrew M. Petros and Haichao Zhang and Paul M. Nimmer and Rodger F. Henry and Steven W. Elmore},
  journal={Journal of the American Chemical Society},
  year={2006},
  volume={128 50},
  pages={16206-12}
}
One of the primary objectives in the design of protein inhibitors is to shape the three-dimensional structures of small molecules to be complementary to the binding site of a target protein. In the course of our efforts to discover potent inhibitors of Bcl-2 family proteins, we found a unique folded conformation adopted by tethered aromatic groups in the ligand that significantly enhanced binding affinity to Bcl-XL. This finding led us to design compounds that were biased by nonbonding… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

The role of lymphatic transport on the systemic bioavailability of the Bcl-2 protein family inhibitors navitoclax (ABT-263) and ABT-199.

Drug metabolism and disposition: the biological fate of chemicals • 2014
View 5 Excerpts
Highly Influenced

Biology and treatment of primary myelofibrosis.

Hematology. American Society of Hematology. Education Program • 2007
View 1 Excerpt

Similar Papers

Loading similar papers…